Population-based cardiac screening tools fail to identify many patients at risk for a first acute coronary syndrome event, ...

A study published in BMC Nephrology explored whether serum angiotensinogen could serve as a reliable biomarker to identify ...

A study finds target lesion failure in 1 in 5 patients with STEMI within 10 years of primary percutaneous coronary ...

The original paper, ‘CXCR4 PET/CT Predicts Left Ventricular Recovery 8 Months After Acute Myocardial Infarction,’ can be found here: ...

Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop ...

Non-ST elevation myocardial infarction (NSTEMI) represents a significant clinical entity within the spectrum of acute ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...

Existing atherosclerotic cardiovascular disease (ASCVD) risk calculators appear to be inadequate, noted researchers led by ...

Extra scrutiny is warranted to identify the underlying causes of chest pain in patients with nonobstructive coronary disease ...

There’s a hidden personality type quietly shaping people’s health, relationships, and stress, and most people don’t even know ...

Once-weekly semaglutide 2.4 mg reduced the risk for major adverse cardiovascular events among adults with overweight or obesity who were at risk for atherosclerotic cardiovascular disease, according ...

Let’s test your knowledge! A 55-year-old woman has been fatigued for the last few days. Suddenly, she feels lightheaded and ...